These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 6731981)

  • 1. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates.
    Kuttler KL; Zaugg JL; Johnson LW
    Am J Vet Res; 1984 Nov; 45(11):2223-6. PubMed ID: 6084430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplasma marginale infections in American bison: experimental infection and serologic study.
    Zaugg JL; Kuttler KL
    Am J Vet Res; 1985 Feb; 46(2):438-41. PubMed ID: 3994109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay for Anaplasma marginale antibodies in cattle.
    Schuntner CA; Leatch G
    Am J Vet Res; 1988 Apr; 49(4):504-7. PubMed ID: 3377309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine anaplasmosis: susceptibility of seronegative cows from an infected herd to experimental infection with Anaplasma marginale.
    Lincoln SD; Zaugg JL; Maas J
    J Am Vet Med Assoc; 1987 Jan; 190(2):171-3. PubMed ID: 3818429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of vaccine-induced immunity to anaplasmosis without induction of persistent postvaccinal complement-fixing and agglutinating antibodies in yearling steers.
    Corrier DE; Johnson JS; Wagner GG
    Am J Vet Res; 1985 Mar; 46(3):583-6. PubMed ID: 3994127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to bovine anaplasmosis after elimination of the carrier status with oxytetracycline hydrochloride.
    Renshaw HW; Magonigle RA; Eckblad WP; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1976; (80):79-88. PubMed ID: 1078098
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaplasma ovis in Idaho sheep.
    Magonigle RA; Eckblad WP; Lincoln SD; Frank FW
    Am J Vet Res; 1981 Feb; 42(2):199-201. PubMed ID: 7258767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and use of a modified live Anaplasma marginale vaccine in beef heifers in California.
    Henry ET; Norman BB; Fly DE; Wichmann RW; York SM
    J Am Vet Med Assoc; 1983 Jul; 183(1):66-9. PubMed ID: 6874525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative titration of Anaplasma marginale antibodies by card agglutination and complement-fixation tests.
    Amerault TE; Rose JE; Kuttler KL
    Am J Vet Res; 1981 Jun; 42(6):1055-6. PubMed ID: 7283236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to anaplasmosis after elimination of latent Anaplasma marginale infections.
    Richey EJ; Brock WE; Kliewer IO; Jones EW
    Am J Vet Res; 1977 Feb; 38(2):169-70. PubMed ID: 557302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dexamethasone on the recrudescence of Anaplasma marginale in splenectomized calves.
    Kuttler KL; Adams LG
    Am J Vet Res; 1977 Sep; 38(9):1327-30. PubMed ID: 921027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of chlortetracycline for anaplasmosis.
    Richey EJ; Brock WE; Kliewer IO; Jones EW
    Am J Vet Res; 1977 Feb; 38(2):171-2. PubMed ID: 557303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle.
    Coetzee JF; Apley MD; Kocan KM
    Vet Ther; 2006; 7(4):347-60. PubMed ID: 17216590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.